SINOPHARM GROUP CO News

Sinopharm Holdings (1099.HK): The device sector is under pressure and expects steady operation for 25 years

cscNov 7 00:00

HK stocks anomaly | Sinopharm (01099) fell by nearly 4% during the day, performance in the first three quarters fell short of expectations, institutions lowered the company's target price.

Zhitong FinanceOct 30 11:48

Dah Sing: Recommends to shareholding sinopharm (01099) with a target price lowered to HK$24.

Zhitong FinanceOct 29 11:51

Sinopharm Group Target Price Cut to HK$28.46 From HK$30.33 by Nomura >1099.HK

Dow JonesOct 18 12:20

Nomura: lowers sinopharm (01099) target price to 28.46 Hong Kong dollars, maintains a "buy" rating

Zhitong FinanceOct 18 11:26

Bocom Intl: rates the Mainland pharmaceutical industry as "leading", focusing on innovative and consumer-driven targets.

Zhitong FinanceOct 17 09:53

Sinopharm Holdings (1099.HK): Segment management differentiation is optimistic about H2 month-on-month improvement

中信建投證券Sep 10 16:26

Citigroup: Buy rating on Sinopharm (01099) with target price lowered to 26 Hong Kong dollars

Zhitong FinanceAug 27 11:27

HKEx: Sinopharm (01099) continued to fall 4%, with revenue and net profit declining in the first half of the year. Institutions have lowered their earnings forecasts and target prices for the company.

Zhitong FinanceAug 27 11:12

Sinopharm Holdings (01099.HK): 1H24 results are in line with expectations, financial expenses declined year-on-year

Aug 27 08:11

Nomura Adjusts Sinopharm's Price Target to HK$30.33 From HK$32.39, Keeps at Buy

MT NewswiresJul 25 15:53

Nomura: Maintains a "buy" rating on Sinopharm (01099), with a lowered target price of HKD 30.33.

Zhitong FinanceJul 25 10:08

Sinopharm Holdings (01099.HK): Main business maintains growth trend, transformation and innovation continue to advance

Apr 30 19:11

Damo: Target price for Sinopharm Holdings (01099) “increase in holdings” rating reduced to HK$28

Zhitong FinanceApr 19 14:32

Sinopharm Holdings (1099.HK): Shareholders' equity increased 6.2% year-on-year in '23, gross margin is still declining

Apr 3 00:00

Sinopharm Holdings (1099.HK): 2023 results slightly lower than expected; high dividend rate expected to continue

Mar 28 00:00

Sinopharm Holdings (1099.HK): Expense Control Continues to Deepen and Expect Steady Growth in Performance

Mar 26 16:11

Sinopharm Holdings (01099.HK): Performance is in line with expectations, and the cost rate is further optimized

Mar 25 19:16

Daehan Rating | Daiwa: First Sinopharm Holdings “Buy” Rating and Target Price HK$25

Gelonghui FinanceMar 13 13:10

Nomura Adjusts Sinopharm Group's Price Target to HK$32.39 Form HK$33.31, Keeps at Buy

MT NewswiresMar 11 17:02